Funding Irish-founded Nutriband raises millions in fresh fundingCompany intends to file for FDA approval for its proprietary abuse-deterrent technology
Innovation Nutriband extends credit line to $5m as it aims for FDA approvalPharma firm led by Gareth Sheridan optimistic it can secure approval in early 2024 for groundbreaking drug patch
MedTech Nutriband to raise $4m in new Nasdaq offeringIrish-founded pharma company is headed by Gareth Sheridan
Health Nutriband seeks dual listing as it nears market launch for fentanyl patchNasdaq-listed pharma company seeks Upstream listing ahead of FDA approval for its Aversa-based abuse deterrent patches